89bio, Inc

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell 89bio, Inc and other ETFs, options, and stocks.

About ETNB

89bio, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Its product pipeline includes pegozafermin, FGF21, NASH, and SHTG. 

CEO
Rohan Palekar
CEORohan Palekar
Employees
41
Employees41
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
2018
Founded2018
Employees
41
Employees41

ETNB Key Statistics

Market cap
213.34M
Market cap213.34M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
811.97K
Average volume811.97K
High today
$5.70
High today$5.70
Low today
$5.45
Low today$5.45
Open price
$5.70
Open price$5.70
Volume
313.56K
Volume313.56K
52 Week high
$20.69
52 Week high$20.69
52 Week low
$2.00
52 Week low$2.00

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

ETNB Earnings

-$1.41
-$0.94
-$0.47
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, Pre-Market
ActualExpected Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.